Cerebrotendinous Xanthomatosis (CTX) Prevalence Study
Clinical trial NCT02638220 · COMPLETED
Trial details
- NCT number
- NCT02638220
- Sponsor
- Travere Therapeutics, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-09-01
- Primary completion
- 2021-02-19
- Enrollment
- 442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.